Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

$85M approved for healthcare studies

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors, an independent nonprofit organization authorized by Congress, has approved $85 million for 16 new studies to improve care and outcomes for several conditions.

Thumbnail

Acquisition forms nation’s largest telepsychiatry provider

SOC Telemed, the nation’s largest national provider of telemedicine technology to healthcare providers, has acquired behavioral health telemedicine company JSA Health.

Thumbnail

New Medicare Advantage supplemental benefits need oversight

More benefits are coming to Medicare Advantage plans aimed at keeping older Americans in their homes longer, but the uncertainty around these additions—and their cost—means more scrutiny may be needed, according to the Bipartisan Policy Center.

Thumbnail

Anthem, Walmart to collaborate in OTC medicines deal

Health insurance company Anthem has teamed up with Walmart in a bid to improve access to and lower the price of over-the-counter (OTC) medicines and services, the companies announced Monday.

Thumbnail

Guideline-discordant care more common among Medicare beneficiaries than VA patients

U.S. veterans who opt for fee-for-service health systems like Medicare are less likely to receive guideline-concordant care than their counterparts in the Veterans Health Administration (VA), researchers reported in a JAMA Network Open original investigation this month.

Thumbnail

CMS releases $8.6M in healthcare funds to stabilize markets

CMS has awarded $8.6 million in funding to 30 states and the District of Columbia to help stabilize health insurance markets. The funding is part of $250 million earmarked for State Rate Review Grants to improve the process for how sates review proposed health insurance rates.

Thumbnail

Drug makers have made no vows to lower prices, say PBMs

Several major pharmacy benefit managers (PBMs), functional middlemen that negotiate drug prices with manufacturers, say they’ve received no commitments from big drug makers to lower prices, The Hill reported.

FDA announces 3 initiatives to improve medical device development, safety

The FDA announced it is taking steps to advance innovation and surveillance for medical devices through the implementation of three initiatives related to the recent user fee re-authorization, according to an Aug. 16 news release.